Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × anlotinib × Clear all

NCT04665609 2021-03-04

Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular